Imax (IMAX) Research & Development (2010 - 2026)

Imax has disclosed Research & Development across 17 years of filings, most recently posting $1.8 million for Q1 2026.

• Research & Development for Q1 2026 came in at $1.8 million, up 36.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.3 million (up 48.84% YoY), and the FY2025 annual result was $5.8 million, up 13.97% from the prior year.
• Research & Development came in at $1.8 million for Q1 2026 at Imax, up from $1.5 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $2.8 million in Q3 2023 to a low of -$265000.0 in Q3 2024.
• The 5-year median for Research & Development is $1.5 million (2025), against an average of $1.7 million.
• Across the five-year window, Research & Development plunged 109.56% in 2024 and surged 667.92% in 2025, its largest moves.
• Imax's Research & Development stood at $1.6 million in 2022, then surged by 66.69% to $2.7 million in 2023, then sank by 57.75% to $1.2 million in 2024, then grew by 26.17% to $1.5 million in 2025, then grew by 24.33% to $1.8 million in 2026.
• The last three Research & Development figures came in at $1.8 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.